FDA
approval
· 2019-09-17
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)
Summary
The FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide for hypertension. The applicant is Lifestar Pharma LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)